Novel Tricyclic Heteroaryl Compounds as IRAK4 Inhibitors for Treating Cancer, Autoimmune and Inflammatory Diseases.
作者信息
Sabnis Ram W
机构信息
Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
出版信息
ACS Med Chem Lett. 2022 Feb 28;13(3):336-337. doi: 10.1021/acsmedchemlett.2c00060. eCollection 2022 Mar 10.
Abstract
摘要
相似文献
1
Novel Tricyclic Heteroaryl Compounds as IRAK4 Inhibitors for Treating Cancer, Autoimmune and Inflammatory Diseases.新型三环杂芳基化合物作为用于治疗癌症、自身免疫性疾病和炎症性疾病的 IRAK4 抑制剂
ACS Med Chem Lett. 2022 Feb 28;13(3):336-337. doi: 10.1021/acsmedchemlett.2c00060. eCollection 2022 Mar 10.
2
Novel IRAK4 Inhibitors for Treating Asthma, COPD, Cancer, Autoinflammatory Diseases, and Autoimmune Diseases.用于治疗哮喘、慢性阻塞性肺疾病、癌症、自身炎症性疾病和自身免疫性疾病的新型白细胞介素-1受体相关激酶4抑制剂。
ACS Med Chem Lett. 2023 Nov 3;14(12):1617-1618. doi: 10.1021/acsmedchemlett.3c00474. eCollection 2023 Dec 14.
3
Interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors: an updated patent review (2016-2018).白细胞介素-1 受体相关激酶 4（IRAK4）抑制剂：更新的专利审查（2016-2018 年）。
Expert Opin Ther Pat. 2019 Apr;29(4):243-259. doi: 10.1080/13543776.2019.1597850. Epub 2019 Mar 29.
4
Targeting IRAK4 for Degradation with PROTACs.利用PROTAC技术靶向降解白细胞介素-1受体相关激酶4（IRAK4）
ACS Med Chem Lett. 2019 Jun 14;10(7):1081-1085. doi: 10.1021/acsmedchemlett.9b00219. eCollection 2019 Jul 11.
5
Establishing and Validating Cellular Functional Target Engagement Assay for Selective IRAK4 Inhibitor Discovery.建立和验证选择性 IRAK4 抑制剂发现的细胞功能靶标结合测定法。
SLAS Discov. 2021 Sep;26(8):1040-1054. doi: 10.1177/24725552211021074. Epub 2021 Jun 16.
6
Novel Heteroaryl Compounds as CD73 Inhibitors for Treating Cancer.新型杂芳基化合物作为用于治疗癌症的CD73抑制剂
ACS Med Chem Lett. 2024 May 31;15(6):775-776. doi: 10.1021/acsmedchemlett.4c00230. eCollection 2024 Jun 13.
7
Small Molecule Inhibition of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4).小分子抑制白细胞介素-1受体相关激酶4（IRAK4）
Prog Med Chem. 2017;56:117-163. doi: 10.1016/bs.pmch.2016.11.004. Epub 2017 Feb 14.
8
Efforts towards the optimization of a bi-aryl class of potent IRAK4 inhibitors.致力于优化一类有效的双芳基 IRAK4 抑制剂。
Bioorg Med Chem Lett. 2016 Sep 1;26(17):4250-5. doi: 10.1016/j.bmcl.2016.07.048. Epub 2016 Jul 22.
9
IRAK4 kinase activity is required for Th17 differentiation and Th17-mediated disease.IRAK4激酶活性是Th17细胞分化和Th17介导疾病所必需的。
J Immunol. 2009 Jul 1;183(1):568-77. doi: 10.4049/jimmunol.0802361.
10
Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitors.基于结构设计发现4,6-二氨基烟酰胺作为有效的选择性IRAK4抑制剂。
Bioorg Med Chem Lett. 2017 Nov 1;27(21):4908-4913. doi: 10.1016/j.bmcl.2017.09.029. Epub 2017 Sep 18.
引用本文的文献
1
Novel IRAK4 Inhibitors for Treating Asthma, COPD, Cancer, Autoinflammatory Diseases, and Autoimmune Diseases.用于治疗哮喘、慢性阻塞性肺疾病、癌症、自身炎症性疾病和自身免疫性疾病的新型白细胞介素-1受体相关激酶4抑制剂。
ACS Med Chem Lett. 2023 Nov 3;14(12):1617-1618. doi: 10.1021/acsmedchemlett.3c00474. eCollection 2023 Dec 14.
2
Tolerogenic dendritic cells and TLR4/IRAK4/NF-κB signaling pathway in allergic rhinitis.变应性鼻炎中的耐受树突状细胞和 TLR4/IRAK4/NF-κB 信号通路。
Front Immunol. 2023 Oct 17;14:1276512. doi: 10.3389/fimmu.2023.1276512. eCollection 2023.
本文引用的文献
1
Chemical reagents modulate nucleic acid-activated toll-like receptors.化学试剂调节核酸激活的 Toll 样受体。
Biomed Pharmacother. 2022 Mar;147:112622. doi: 10.1016/j.biopha.2022.112622. Epub 2022 Jan 7.
2
Creating Awareness for Primary Immunodeficiencies in Japan.在日本提高原发性免疫缺陷的认识。
Front Immunol. 2021 Dec 13;12:803459. doi: 10.3389/fimmu.2021.803459. eCollection 2021.
3
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies.IRAK1 和 IRAK4 作为血液系统恶性肿瘤中新兴的治疗靶点。
Curr Opin Hematol. 2022 Jan 1;29(1):8-19. doi: 10.1097/MOH.0000000000000693.
4
Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors.小分子治疗自身免疫和炎症性疾病的方法（第一部分）：激酶抑制剂。
Bioorg Med Chem Lett. 2021 Apr 15;38:127862. doi: 10.1016/j.bmcl.2021.127862. Epub 2021 Feb 18.
5
14-3-3 modulation of the inflammatory response.14-3-3 调节炎症反应。
Pharmacol Res. 2021 Jan;163:105236. doi: 10.1016/j.phrs.2020.105236. Epub 2020 Oct 11.
6
IRAK family in inflammatory autoimmune diseases.IRAK 家族在炎症性自身免疫疾病中的作用。
Autoimmun Rev. 2020 Mar;19(3):102461. doi: 10.1016/j.autrev.2020.102461. Epub 2020 Jan 7.
Zotero 插件